TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response

被引:65
|
作者
Zeng, Zexian [1 ,2 ]
Wong, Cheryl J. [1 ,3 ]
Yang, Lin [1 ]
Ouardaoui, Nofal [1 ]
Li, Dian [1 ]
Zhang, Wubing [1 ,4 ]
Gu, Shengqing [1 ,2 ,5 ,6 ]
Zhang, Yi [1 ,2 ]
Liu, Yang [1 ]
Wang, Xiaoqing [1 ,2 ,5 ,6 ]
Fu, Jingxin [5 ,7 ]
Zhou, Liye [5 ]
Zhang, Boning [1 ,2 ,5 ,6 ]
Kim, Sarah [7 ]
Yates, Kathleen B. [7 ,8 ]
Brown, Myles [5 ,6 ]
Freeman, Gordon J. [5 ]
Uppaluri, Ravindra [5 ,9 ]
Manguso, Robert [7 ,8 ]
Liu, X. Shirley [1 ,2 ,6 ]
机构
[1] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02215 USA
[2] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA
[3] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA
[4] Tongji Univ, Sch Life Sci & Technol, Shanghai 200060, Peoples R China
[5] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA
[6] Dana Farber Canc Inst, Ctr Funct Canc Epigenet, Boston, MA 02215 USA
[7] Broad Inst Harvard & MIT, Boston, MA 02129 USA
[8] Massachusetts Gen Hosp, Ctr Canc Res, Harvard Med Sch, Charlestown, MA 02114 USA
[9] Brigham & Womens Hosp, Dept Surg, Boston, MA 02215 USA
基金
美国国家卫生研究院;
关键词
MTB;
D O I
10.1093/nar/gkab804
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Syngeneic mouse models are tumors derived from murine cancer cells engrafted on genetically identical mouse strains. They are widely used tools for studying tumor immunity and immunotherapy response in the context of a fully functional murine immune system. Large volumes of syngeneic mouse tumor expression profiles under different immunotherapy treatments have been generated, although a lack of systematic collection and analysis makes data reuse challenging. We present Tumor Immune Syngeneic MOuse (TISMO), a database with an extensive collection of syngeneic mouse model profiles with interactive visualization features. TISMO contains 605 in vitro RNA-seq samples from 49 syngeneic cancer cell lines across 23 cancer types, of which 195 underwent cytokine treatment. TISMO also includes 1518 in vivo RNA-seq samples from 68 syngeneic mouse tumor models across 19 cancer types, of which 832 were from immune checkpoint blockade (ICB) studies. We manually annotated the sample metadata, such as cell line, mouse strain, transplantation site, treatment, and response status, and uniformly processed and quality-controlled the RNA-seq data. Besides data download, TISMO provides interactive web interfaces to investigate whether specific gene expression, pathway enrichment, or immune infiltration level is associated with differential immunotherapy response. TISMO is available at http://tismo.cistrome.org.
引用
收藏
页码:D1391 / D1397
页数:7
相关论文
共 50 条
  • [21] PASSIVE IMMUNOTHERAPY WITH SYNGENEIC ANTI-TUMOR SERUM .4. IMMUNOTHERAPY OF MURINE TUMOR WITH SYNGENEIC ANTI-TUMOR SERUM PLUS BCG
    YAMAZAKI, M
    SAITO, M
    ABE, S
    MIZUNO, D
    JAPANESE JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 53 (01): : 27 - 32
  • [22] CELLULAR INTERACTIONS IN TUMOR-IMMUNITY AGAINST SYNGENEIC TUMOR IN THE MOUSE - MECHANISM OF TARGET-CELL LYSIS
    FUJIMOTO, S
    TAKATA, M
    TOKO, T
    UCLA SYMPOSIA ON MOLECULAR AND CELLULAR BIOLOGY, 1982, 24 : 319 - 334
  • [23] RELATIONSHIP OF ALLOREACTIVITY TO SYNGENEIC TUMOR-IMMUNITY
    GREENE, MI
    PERRY, LL
    TRANSPLANTATION PROCEEDINGS, 1980, 12 (01) : 80 - 86
  • [24] ENHANCEMENT OF SYNGENEIC TUMOR IMMUNITY BY ADULT THYMECTOMY
    REINISCH, CL
    ANDREW, SL
    FEDERATION PROCEEDINGS, 1978, 37 (06) : 1382 - 1382
  • [25] A highly potent HPK1 inhibitor augments immune cell activation and anti-tumor immunity in a syngeneic tumor mouse model
    Liu, Hao
    Wu, Lei
    Feng, Song
    Huang, Wei
    Li, Huijuan
    Lin, Jing
    Liu, Yangyang
    Mei, Liufeng
    Ren, Baoqi
    Xie, Julie
    Yao, Lili
    Zhong, Wenge
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [26] Noninvasive tumor tracking and characterization of stage-specific immunity in a syngeneic mouse model of ovarian cancer.
    Wilson, Amy L.
    Wilson, Kirsty L.
    Bilandzic, Maree
    Moffitt, Laura R.
    Plebanski, Magdalena
    Stephens, Andrew N.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 115 - 115
  • [27] Depth of tumor implantation predicts response to in situ vaccination in a syngeneic melanoma model - an important variable influencing response to immunotherapy
    Carlson, Peter
    Mohan, Manasi
    Rodriguez, Mat
    Subbotin, Vladimir
    Erbe, Amy
    Morris, Zachary
    Rakhmilevich, Alexander
    Sondel, Paul
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [28] PASSIVE IMMUNOTHERAPY WITH SYNGENEIC ANTI-TUMOR SERUM - PROTECTIVE EFFECT OF SYNGENEIC ANTI-TUMOR SERUM ON MAMMARY-TUMOR IN A SYNGENEIC HOST
    SHINODA, H
    YAMAZAKI, M
    MIZUNO, D
    GANN, 1977, 68 (05): : 561 - 565
  • [29] ENHANCEMENT OF CONCOMITANT IMMUNITY AFTER RADIATION-THERAPY AND IMMUNOTHERAPY IN A SYNGENEIC MURINE TUMOR SYSTEM
    DENEUFBOURG, JM
    ACTA RADIOLOGICA ONCOLOGY, 1982, 21 (05): : 345 - 348
  • [30] Anti-tumor effect of aquaporin 3 monoclonal antibody on syngeneic mouse tumor model
    Tanaka, Manami
    Ito, Anmi
    Shiozawa, Seiji
    Hara-Chikuma, Mariko
    TRANSLATIONAL ONCOLOGY, 2022, 24